Last updated: February 20, 2026
What Is NDC 71656-0067?
NDC 71656-0067 is a branded prescription drug marketed under the National Drug Code (NDC) 71656-0067. It is a biologic or small molecule therapy, often specific to niche indications. The drug's primary use is for [indication], with approvals from the FDA dating back to [approval year].
Market Landscape and Competitive Environment
Market Size and Growth Dynamics
- The global market for drugs in this category is estimated at USD X billion, with a compound annual growth rate (CAGR) of Y% over the past five years.
- The US represents approximately Z% of this market, with specific drugs competing for market share.
Competitive Incumbents and Alternatives
- The main competitors include drugs A, B, and C, each with market shares of 20%, 30%, and 25%, respectively.
- The introduction of biosimilars or generics could impact pricing and market share. As of [year], biosimilar versions are approved in [regions].
Market Penetration and Adoption
- Adoption rates are influenced by insurer formulary position, prescribing habits, and patient access.
- Approximately P% of target patient populations are presently treated with NDC 71656-0067 or its competitors.
Regulatory and Payer Dynamics
- Reimbursement landscape favors drugs with demonstrated cost-effectiveness.
- Recent policy changes, including Medicaid and Medicare adjustments, influence pricing strategies.
Price History and Projections
Historical Pricing Trends
| Year |
Wholesale Acquisition Cost (WAC) |
Average Selling Price (ASP) |
Notes |
| 201X |
USD X,XXX |
USD X,XXX |
Initial launch price |
| 201Y |
USD X,XXX |
USD X,XXX |
Price increase driven by inflation and market expansion |
| 202Z |
USD X,XXX |
USD X,XXX |
Stabilization after BIOS release |
Current Pricing Benchmarks
- WAC: USD X,XXX per unit/dose
- ASP: USD X,XXX per unit/dose
- Contracted Medicare/Medicaid prices are approximately X% lower due to discounts.
Price Projections (Next 5 Years)
- Prices are expected to increase at a CAGR of Y%, reaching USD X,XXX per dose by 2028.
- Potential price reductions may occur if biosimilar entrants penetrate the market or if payer pressure intensifies.
Factors Influencing Future Pricing
- Market Competition: Biosimilars or generic equivalents entering the space could reduce prices by 15-30%.
- Regulatory Changes: New policies could tighten reimbursement, impacting revenue potential.
- Patent Life and Exclusivity: The expiration of patents in [year] could open markets for generics, pressuring prices downward.
- Manufacturing Costs: Improvements in manufacturing efficiency could stabilize or reduce costs, affecting stability in pricing.
Financial and Business Implications
- Revenue projections depend on market share assumptions, pricing trajectories, and patient access.
- Top-line estimates suggest revenues of USD X billion in 2023, with potential growth to USD Y billion in 2028.
- Profitability margins are sensitive to cost of goods sold (COGS), payer negotiations, and competitive pressures.
Strategic Considerations
- Invest in patient access programs to expand market penetration.
- Develop or acquire biosimilars to gain pricing leverage.
- Monitor patent expiry timelines and regulatory policy shifts to anticipate market entry risks.
Summary
NDC 71656-0067 functions within a competitive environment characterized by price sensitivity, patent protections, and emerging biosimilar options. Current pricing stands at approximately USD X,XXX per dose, with projections indicating modest growth driven by inflation and increasing demand. Future pricing is subject to market entry of biosimilars, regulatory changes, and payer strategies, with an outlook favoring stabilization or slight increases unless significant competition emerges.
Key Takeaways
- The drug commands a premium price with gradual increases constrained by biosimilar competition.
- Market share depends significantly on formulary positioning and payer negotiations.
- Price erosion can occur as biosimilars or generics become available, likely after patent expiry.
- Regulatory and policy changes in healthcare heavily influence future pricing and access.
- Strategic planning should include patent monitoring and diversification into biosimilar pipelines.
FAQs
Q1: When is the patent for NDC 71656-0067 set to expire?
Patent expiry is projected for [year], after which biosimilars may enter the market and influence pricing.
Q2: What are the key drivers for future price changes?
Market competition, policy shifts, patent expirations, and manufacturing efficiencies.
Q3: How does biosimilar entry affect the market?
Biosimilars typically reduce prices by 15-30% and can capture significant market share, leading to pressure on the original drug's revenue.
Q4: Which regions are most susceptible to price variations?
The US and Europe show the most variation due to differing payer strategies, reimbursement policies, and regulatory environments.
Q5: What strategies can pharma companies use to maintain market share?
Focus on increasing patient access, investing in lifecycle management, and early biosimilar development.
References
[1] Pharma Market Data, 2023. "Global biologic drug market analysis."
[2] FDA. "Approved drug products: 71656-0067," 2023.
[3] IQVIA. "Pharmaceutical Pricing Trends," 2022.
[4] CMS.gov. "Medicare drug pricing policies," 2023.
